These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7423334)

  • 1. Subcutaneous infection with phialophora richardsiae and its susceptibility to 5-fluorocytosine, amphotericin B and miconazole.
    Corrado ML; Weitzman I; Stanek A; Goetz R; Agyare E
    Sabouraudia; 1980 Jun; 18(2):97-104. PubMed ID: 7423334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
    Paniagua GL; Monroy E; Negrete E; Vaca S
    Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
    Odds FC
    Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phialophora parasitica, an emerging pathogen.
    Weitzman I; Gordon MA; Henderson RW; Lapa EW
    Sabouraudia; 1984; 22(4):331-9. PubMed ID: 6095471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
    Ahearn DG; McGlohn MS
    J Clin Microbiol; 1984 Mar; 19(3):412-6. PubMed ID: 6325491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sensitivity of Candida to 5-fluorocytosine and amphotericin B].
    Pawlik B; Budak A; Macura A; Laskownicka Z
    Med Dosw Mikrobiol; 1978; 30(1):43-8. PubMed ID: 692181
    [No Abstract]   [Full Text] [Related]  

  • 7. [Synergistic action of amphotericin B and 5-fluorocytosine on Fonsecaea pedrosoi].
    de Resende MA
    Rev Inst Med Trop Sao Paulo; 1979; 21(6):344-6. PubMed ID: 550288
    [No Abstract]   [Full Text] [Related]  

  • 8. Phialophora richardsiae isolated from infected human bone: morphological, physiological and antifungal susceptibility studies.
    Yangco BG; TeStrake D; Okafor J
    Mycopathologia; 1984 May; 86(2):103-11. PubMed ID: 6738670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sensitivity of Candida spp. to 5-fluorocytosine, amphotericin B and imidazoles. Antifongiogram of 120 strains isolated at the Vaudois University Hospital Center during the autumn-winter seasons of 1978 and 1980].
    Sakellarides E
    Schweiz Med Wochenschr; 1981 Sep; 111(37):1367-72. PubMed ID: 7291960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical pharmacology of antifungal agents in deep mycoses].
    Azanza Perea JR; Honorato Pérez J; Cuena Boy R
    Rev Med Univ Navarra; 1983 Sep; 27(3):19-24. PubMed ID: 6669848
    [No Abstract]   [Full Text] [Related]  

  • 11. Turbidimetric studies of growth inhibition of yeasts with three drugs: inquiry into inoculum-dependent susceptibility testing, time of onset of drug effect, and implications for current and newer methods.
    Galgiant JN; Stevens DA
    Antimicrob Agents Chemother; 1978 Feb; 13(2):249-54. PubMed ID: 646347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro comparison of the antifungal activities of R34,000, miconazole and amphotericin B.
    Dixon DM; Wagner GE; Shadomy S; Shadomy HJ
    Chemotherapy; 1978; 24(6):364-7. PubMed ID: 699677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory methods for flucytosine (5-fluorocytosine). Report of a Working Group of the British Society for Mycopathology.
    J Antimicrob Chemother; 1984 Jul; 14(1):1-8. PubMed ID: 6480540
    [No Abstract]   [Full Text] [Related]  

  • 14. Zygomycosis caused by Cunninghamella bertholletiae: mycologic aspects.
    Schell WA; Johnson MG; McGinnis MR; Weitzman I; Crist MY
    Arch Pathol Lab Med; 1982 Jun; 106(6):287-91. PubMed ID: 6896435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antifungal susceptibility of fungi isolated from respiratory tract of patients and other sources.
    Chaturvedi VP; Chaturvedi S; Khan ZU; Randhawa HS
    Indian J Chest Dis Allied Sci; 1988; 30(1):36-40. PubMed ID: 3169869
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro studies of amphotericin B in combination with the imidazole antifungal compounds clotrimazole and miconazole.
    Cosgrove RF; Beezer AE; Miles RJ
    J Infect Dis; 1978 Nov; 138(5):681-5. PubMed ID: 361901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphotericin B and 5-fluorocytosine: effects on cell-mediated immunity.
    Roselle GA; Kauffman CA
    Clin Exp Immunol; 1980 Apr; 40(1):186-92. PubMed ID: 6993075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the morphology of Phialophora dermatitidis isolated in China and its susceptibility to amphotericin B and mycostatin].
    Jen TM; Lin WH
    Taiwan Yi Xue Hui Za Zhi; 1973 Dec; 72(12):671-80. PubMed ID: 4522055
    [No Abstract]   [Full Text] [Related]  

  • 19. Atypical eumycetoma caused by Phialophora parasitica successfully treated with itraconazole and flucytosine.
    Hood SV; Moore CB; Cheesbrough JS; Mene A; Denning DW
    Br J Dermatol; 1997 Jun; 136(6):953-6. PubMed ID: 9217835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective systemic antifungal agents.
    Lefrock JL; Smith BR
    Am Fam Physician; 1984 Dec; 30(6):162-7. PubMed ID: 6095631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.